https://doi.org/10.1186/s13045-023-01476-8
W
Walid Macaron
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.0K
Citations
15
h-index
18
i10-index
Walid Macaron is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 15, co-authored 51 publications.
ORCID: 0000-0001-5168-0163Papers by this author
worksA phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
2023 · Journal of Hematology & Oncology · 49 citations
Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors
2022 · Current Problems in Cancer · 13 citations
https://doi.org/10.1016/j.currproblcancer.2022.100859
Liquid biopsies and minimal residual disease in lymphoid malignancies
2023 · Frontiers in Oncology · 7 citations
https://doi.org/10.3389/fonc.2023.1173701
EXABS-134-ALL: Management of High-Risk Philadelphia Chromosome-Positive ALL
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)00321-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat